Patents by Inventor Martin Zillmann

Martin Zillmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030073101
    Abstract: Methods for determing genotypes and haplotypes of genes are described. Also described are single nucleotide polymorphisms and haplotypes in the ApoE gene and methods of using that information.
    Type: Application
    Filed: April 4, 2002
    Publication date: April 17, 2003
    Inventors: Jeffrey Olson, Martin Zillmann, Vincent P. Stanton
  • Publication number: 20020150943
    Abstract: The present invention relates to a method for genotyping a diploid organism by cleaving segments of two alleles such that 7-20 nucleotide fragments that contain a suspected polymorphic locus are produced and comparing the masses of those fragments.
    Type: Application
    Filed: March 26, 2002
    Publication date: October 17, 2002
    Applicant: Variagenics, Inc.
    Inventors: Vincent P. Stanton, Jeffrey Olson, Jia Liu Wolfe, Martin Zillmann
  • Publication number: 20020072637
    Abstract: A single-stage method for producing &agr;-hydroxy ethers by oxidizing olefinic substrates with organic hydroperoxides and opening the resultant oxirane ring by means of monovalent or polyvalent alcohols wherein a molybdenum compound in combination with a compound selected from the group consisting of boron trifluoride, aluminum oxides, 1,8-diazabicyclo-[5.4.0]-undec-7-ene or 1,4-diazabicyclo-[2.2.2]-octane, and mixtures thereof is used as a catalyst system.
    Type: Application
    Filed: November 8, 2001
    Publication date: June 13, 2002
    Inventors: Mark Rusch gen. Klaas, Siegfried Warwel, Hans-Martin Zillmann, Klaus Kwetkat
  • Patent number: 6380439
    Abstract: A single-stage method for producing &agr;-hydroxy ethers by oxidizing olefinic substrates with organic hydroperoxides and opening the resultant oxirane ring by means of monovalent or polyvalent alcohols wherein a molybdenum compound in combination with a compound selected from the group consisting of boron trifluoride, aluminum oxides, 1,8-diazabicyclo-[5.4.0]-undec-7-ene or 1,4-diazabicyclo-[2.2.2]-octane, and mixtures thereof is used as a catalyst system.
    Type: Grant
    Filed: January 25, 2000
    Date of Patent: April 30, 2002
    Assignee: RWE-DEA Aktiengesellschaft fur Mineraloel und Chemie
    Inventors: Mark RĂ¼sch gen. Klaas, Siegfried Warwel, Hans-Martin Zillmann, Klaus Kwetkat
  • Publication number: 20010034023
    Abstract: Methods for identifying and utilizing variances in genes relating to efficacy and safety of medical therapy and other aspects of medical therapy are described, including methods for selecting an effective treatment.
    Type: Application
    Filed: December 7, 2000
    Publication date: October 25, 2001
    Inventors: Vincent P. Stanton, Martin Zillmann